Parnell Pharmaceuticals (CE) Stock Quote PARNF - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

0.0001

Bid

0.00

Ask

0.00

Volume

0.00 Day's Range 0.00

0.000001 52 Week Range 0.0008

Market Cap

12.038k

Previous Close

0.0001

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

2,200

Shares Outstanding

120,377,529

Dividend Yield

PE Ratio

0.00

Earnings Per Share (EPS)

-0.05

Revenue

35.43M

Net Profit

-5.74M

Parnell (OTC: PARNF) is a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal and human health solutions. Parnell is a technology and clinical science leader in dairy reproduction, marketing its proprietary brands estroPLAN and GONAbreed... Parnell (OTC: PARNF) is a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal and human health solutions. Parnell is a technology and clinical science leader in dairy reproduction, marketing its proprietary brands estroPLAN and GONAbreed via its dedicated sales force and digital technology mySYNCH in the USA and Australia-New Zealand, and via distributors in other markets. Parnell has a rapidly growing contract manufacturing business supplying industry majors with specialized sterile injectable products. In companion animal, Parnell manufactures and markets its proprietary canine osteoarthritis brands Zydax and Glyde. For more information on the company and its products, please visit www.parnell.com. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.parnell.com

Headquarters

Sydney, New South Wales, Aus

Founded

1970

Parnell Pharmaceuticals Holdings Ltd (CE) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker PARNF. The last closing price for Parnell Pharmaceuticals (CE) was $0. Over the last year, Parnell Pharmaceuticals (CE) shares have traded in a share price range of $ 0.000001 to $ 0.0008.

Parnell Pharmaceuticals (CE) currently has 120,377,529 shares outstanding. The market capitalization of Parnell Pharmaceuticals (CE) is $12,037.75 . Parnell Pharmaceuticals (CE) has a price to earnings ratio (PE ratio) of 0.00.

No news to show yet.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0.0001	0.0001	0.0001	2200	0.0001	CS
26	9.9E-5	9900	1.0E-6	0.0001	1.0E-6	2567	5.757E-5	CS
52	-0.0004	-80	0.0005	0.0008	1.0E-6	29902	0.00028659	CS
156	-0.2599	-99.9615384615	0.26	0.27	1.0E-6	11297	0.03407603	CS
260	-0.2099	-99.9523809524	0.21	0.89	1.0E-6	12548	0.20830094	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
DCAPUnity Wealth Partners Dynamic Capital Appreciation & Options ETF	20.10 (839.25%)	128.82k
RGCRegencell Bioscience Holdings Ltd	$ 15.15 (349.55%)	1.34M
ATPCAgape ATP Corporation	$ 0.2262 (58.18%)	107.32M
SLRXSalarius Pharmaceuticals Inc	$ 2.34 (51.95%)	60.04M
GSUNGolden Sun Health Technology Group Ltd	$ 7.46 (45.42%)	590.09k
FLYEFly E Group Inc	$ 1.1601 (-81.82%)	25.44M
RNAZTransCode Therapeutics Inc	$ 0.3035 (-61.70%)	9.78M
JAGXJaguar Health Inc	$ 1.755 (-58.90%)	15.47M
MIRAMIRA Pharmaceuticals Inc	$ 2.55 (-49.10%)	25.64M
IVPInspire Veterinary Partners Inc	$ 5.19 (-43.83%)	1.67M
SLNASelina Hospitality PLC	$ 0.026 (-29.73%)	220.33M
SPWRSunPower Corporation	$ 0.9514 (32.91%)	186.76M
NVDANVIDIA Corporation	$ 122.59 (-0.77%)	173.91M
ADILAdial Pharmaceuticals Inc	$ 1.3422 (26.62%)	160.04M
HOLOMicroCloud Hologram Inc	$ 0.588 (26.07%)	135.56M